Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Pacing and Clinical Electrophysiology : PACE|December 2, 2023
Conduction velocity mapping in atrial fibrillation using omnipolar technologyYousaku Okubo, Naoto Oguri, Takumi Sakai, et al.Journal of Arrhythmia|January 27, 2025
Novel omnipolar mapping technology for effective superior vena cava isolation: A randomized clinical trialNaoto Oguri, Yousaku Okubo, Naoki Ishibashi, et al.Cancer Biology & Therapy|January 29, 2010
MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracilHiroshi Hirai, Tsuyoshi Arai, Megumu Okada, et al.Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|August 20, 2024
The benefits of ablation using TactiFlex compared with TactiCath in an ex vivo model: a face-to-face experimental comparison studyYodo Odake, Takehito Tokuyama, Kazutaka Aonuma, et al.Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|June 8, 2026
Utility of slow conduction velocity area guided ablation in patients with persistent atrial fibrillationYousaku Okubo, Shunsuke Ishida, Sho Okamura, et al.Journal of Cardiovascular Electrophysiology|March 24, 2025
Clinical Features of Brugada Syndrome Patients With SCN5A VariantsSho Okamura, Hidenori Ochi, Mika Nakashima, et al.Heart Rhythm O2|July 30, 2025
Risk stratification of major arrhythmia events in Japanese patients with Brugada syndrome using machine learning modelsShunsuke Ishida, Motoki Furutani, Mika Nakashima, et al.Journal of Cardiovascular Electrophysiology|April 11, 2026
Clinical Prediction Model for Unsuccessful Left Bundle Branch Area PacingYousaku Okubo, Junji Maeda, Shogo Miyamoto, et al.Molecular Cancer Therapeutics|January 8, 2010
MK-5108, a highly selective Aurora-A kinase inhibitor, shows antitumor activity alone and in combination with docetaxelToshiyasu Shimomura, Shinichi Hasako, Yoko Nakatsuru, et al.International Journal of Cardiology|September 21, 2024
Decreased plasma cell-free mitochondrial DNA may be a new biomarker of tachycardia-induced cardiomyopathy in patients with atrial fibrillationShogo Miyamoto, Takehito Tokuyama, Yousaku Okubo, et al.Pageof 3